In control experiments, both native GLP1 and GLP1(936) have been shown to produce vasodilation and increase cGMP release from isolated, preconstricted blood vessels when tested ex vivo
The blood-brain barrier (BBB) restricts drug penetration into the CNS, limiting the bioavailability of therapeutic agents (Alajangi et al
Antiepileptic Drug Therapy for Status Epilepticus
Other studies have reported minimal safety concerns regarding short-term supplementation of up to 14 grams per day ( Overall, it is believed that the short-term use of supplements is likely safe
You will need your GLP-1 medication pen or autoinjector, alcohol wipes, a sharps disposal container, and clean hands
Many peptide programs use injections, but routes and protocols vary